Benevich Ericinsider trades
In SEC Form 4 filings, Benevich Eric is listed as Chief Commercial Officer of Neurocrine Biosciences Inc (NBIX). In the last 90 days, Benevich Eric sold $333K of Neurocrine Biosciences Inc (NBIX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| NBIXNeurocrine Biosciences Inc | Chief Commercial Officer | 5 | Sep 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | A | 6,275 | $0.00 | $0 | 70,683 | No | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | F | 3,386 | $156.22 | $528,961 | 67,297 | No | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 9 | Sep 10 | M | 3,194 | $43.24 | $138,109 | 66,562 | Yes | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 9 | Sep 10 | S | 2,154 | $154.61 | Sale −$333,030 | 64,408 | Yes | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 9 | Sep 10 | M · derivative | 3,194 | $43.24 | $138,109 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.